Your browser doesn't support javascript.
loading
Fulminant ulcerative colitis complicated by treatment-refractory bacteremia.
Krease, Michael; Stroup, Jeff; Som, Mousumi; Shepard, Benjamin.
Afiliação
  • Krease M; Department of Internal Medicine (Krease, Stroup, Som) and Division of Gastroenterology (Shepard), Oklahoma State University Medical Center, Tulsa, Oklahoma.
  • Stroup J; Department of Internal Medicine (Krease, Stroup, Som) and Division of Gastroenterology (Shepard), Oklahoma State University Medical Center, Tulsa, Oklahoma.
  • Som M; Department of Internal Medicine (Krease, Stroup, Som) and Division of Gastroenterology (Shepard), Oklahoma State University Medical Center, Tulsa, Oklahoma.
  • Shepard B; Department of Internal Medicine (Krease, Stroup, Som) and Division of Gastroenterology (Shepard), Oklahoma State University Medical Center, Tulsa, Oklahoma.
Proc (Bayl Univ Med Cent) ; 29(4): 407-408, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27695178
Severe ulcerative colitis is defined by more than six bloody stools daily and evidence of toxicity, demonstrated by fever, tachycardia, anemia, or an elevated erythrocyte sedimentation rate. Fulminant disease represents a subset of severe disease with signs and symptoms suggestive of increased toxicity. Treatment of severe colitis includes intravenous corticosteroid administration, with consideration of intravenous infliximab 5 mg/kg. Failure to show improvement after 3 to 5 days is an indication for colectomy or treatment with intravenous cyclosporine. We report a 23-year-old Hispanic woman with decompensated cirrhosis presenting with new-onset fulminant ulcerative colitis and resulting polymicrobial bacteremia, requiring colectomy for infection source control and colitis treatment.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article